Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
This article was originally published in The Pink Sheet Daily
Executive Summary
New “integrated medicine” category begs FDA reg clarification.
You may also be interested in...
Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
Bayer’s combination of aspirin and cholesterol-lowering supplement has industry stakeholders asking how FDA can avoid issuing a warning.
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement